Data monitoring committees for clinical trials and the role of the statistician
- Author
- Alexander Schacht and Benjamin Piske, biometricians, statisticians and leaders in the pharma industry
- Published
- Tue 23 Feb 2021
- Episode Link
- https://podcastae8fac.podigee.io/160-data-monitoring-committees-for-clinical-trials-and-the-role-of-the-statistician
Interview with David Kerr
Join us while we discuss these questions with David and learn more about the following points:
- How did David get to this position as a biostatistician at a CRO?
- How is it made sure that information from the DMC stays within the DMC?
- What is David's most challenging and most exciting experience he had while working in a DMC setting?
- When working on open-label trials, it is sometimes requested to “artificially” blind the date but have a DMC review the unblinded data. Has he come across these settings as well, and what’s the challenge he sees here?
References:
https://www.linkedin.com/in/dmcdavid/
https://www.cytel.com/blog/0-key-qualifications-for-independent-statisticians-reporting-to-the-dmc
Listen to this episode and share it with your friends and colleagues!
